These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18997570)

  • 1. Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: a review.
    Fleschler R; Peskin MF
    MCN Am J Matern Child Nurs; 2008; 33(6):355-61; quiz 362-3. PubMed ID: 18997570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects.
    Hallberg P; Sjöblom V
    J Clin Psychopharmacol; 2005 Feb; 25(1):59-73. PubMed ID: 15643101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSRI use during pregnancy.
    Tran H; Robb AS
    Semin Perinatol; 2015 Nov; 39(7):545-7. PubMed ID: 26428019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
    Cantor Sackett J; Weller RA; Weller EB
    Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal and neonatal effects of maternal drug treatment for depression.
    Belik J
    Semin Perinatol; 2008 Oct; 32(5):350-4. PubMed ID: 18929158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN; Bos AF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy.
    ACOG Committee on Obstetric Practice
    Obstet Gynecol; 2006 Dec; 108(6):1601-3. PubMed ID: 17138801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
    Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of selective serotonin reuptake inhibitors in pregnancy.
    Wen SW; Walker M
    J Obstet Gynaecol Can; 2004 Sep; 26(9):819-22. PubMed ID: 15361279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?
    Koren G; Matsui D; Einarson A; Knoppert D; Steiner M
    CMAJ; 2005 May; 172(11):1457-9. PubMed ID: 15911861
    [No Abstract]   [Full Text] [Related]  

  • 12. Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression.
    Werremeyer A
    Am J Psychiatry; 2009 Nov; 166(11):1298. PubMed ID: 19884241
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors in pregnancy.
    Bellissima V; Ververs TF; Visser GH; Gazzolo D
    Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of selective serotonin reuptake inhibitors in pregnancy.
    Alwan S; Friedman JM
    CNS Drugs; 2009; 23(6):493-509. PubMed ID: 19480468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rock and a hard place: The selective serotonin reuptake inhibitor dilemmas in addressing perinatal mood and anxiety disorders.
    Stohl H; Kohm AD; Dossett E
    J Neonatal Perinatal Med; 2016; 9(1):1-5. PubMed ID: 27002264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal depression and antidepressants during pregnancy: unraveling the complex interactions for the offspring.
    Olivier JD; Åkerud H; Sundström Poromaa I
    Eur J Pharmacol; 2015 Apr; 753():257-62. PubMed ID: 25094036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.
    Laine K; Heikkinen T; Ekblad U; Kero P
    Arch Gen Psychiatry; 2003 Jul; 60(7):720-6. PubMed ID: 12860776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
    Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
    J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.
    Alwan S; Friedman JM; Chambers C
    CNS Drugs; 2016 Jun; 30(6):499-515. PubMed ID: 27138915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.